Full-Time

Hrbp Head – Pipeline & G&a

Posted on 11/4/2024

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Expert

Somerset County, NJ, USA

Hybrid position requiring in-office presence.

Category
Human Resources
People & HR

You match the following Legend Biotech's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Advanced degree in Human Resources, Business Administration, or a related field.
  • Minimum of 10 years of progressive HR leadership experience, including experience in building and leading an HRBP team to drive impactful HR strategies.
  • Proven expertise in strategic workforce planning, organizational design, and leadership development, with experience managing transformational initiatives.
  • Strong business acumen, analytical thinking, and the ability to translate complex HR strategies into actionable business outcomes.
  • Exceptional communication and influencing skills, with the ability to foster collaboration across diverse, multicultural teams.
Responsibilities
  • Act as a trusted advisor to Global Pipeline and G&A senior leaders, providing strategic HR guidance that aligns with their business priorities and drives competitive advantage.
  • Leverage data insights to support workforce planning, organizational structure, talent acquisition, and other HR needs critical to business success.
  • Develop and lead a team of HRBPs dedicated to supporting the Global Pipeline and G&A functions, fostering a culture of collaboration and continuous improvement within HR.
  • Collaborate with Talent Development and Talent Acquisition teams to design and execute a comprehensive talent strategy, focused on developing leadership pipelines, enhancing skill growth, and providing a high-quality talent pool to support both the Global Pipeline and G&A functions.
  • Design and implement organizational structures that support the strategic goals of both Global Pipeline and G&A, ensuring agility and readiness for future growth.
  • Foster a culture that supports engagement, innovation, and collaboration, ensuring a work environment where employees feel motivated and empowered.
Desired Qualifications
  • Background in high-growth or entrepreneurial environments is an advantage.
  • Prior international/cross regional experiences working in the biotechnology and/or pharmaceutical industry is highly preferred.

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates within the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments. Their goal is to provide effective treatments for hard-to-treat diseases through innovative cell therapy solutions.

Company Stage

IPO

Total Funding

$146.4M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-1%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
  • New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
  • Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

What critics are saying

  • Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
  • Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
  • Financial strain from new R&D facility could affect operational focus if advancements lag.

What makes Legend Biotech unique

  • Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
  • The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
  • Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

INACTIVE